YSB Inc

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, YSB Inc has already paid €0.014 in dividends. The last payout was in June.

Financials

In the last quarter, YSB Inc had revenue of €1.31bn and net profit of €14.1m

(EUR)	June 2026	YoY
Revenue	1.31bn	-
Gross profit	146.44m	-
Net profit	14.1m	-
EBITDA	19.9m	-

Fundamentals

Metric	Value
Market capitalization	€264.02m
Number of shares	685.08m
52-week high/low	€0.97 - €0.34
Dividend yield	3.43%
Dividends TTM	€0.014
Beta	0.47
P/E ratio	10.62
PEG ratio	0.08
P/B ratio	0.81
P/S ratio	0.09

Company profile

YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. It develops ClouDiagnos for diagnostic testing service; wePharmacy, a 24-hour access smart unmanned pharmaceutical booth that connects buyers and the end customers with pharmacist services; SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. The company also engages in the wholesale and retail of pharmaceutical and healthcare products. In addition, it provides medical testing services. The company was founded in 2015 and is headquartered in Guangzhou, China.